Low-cost OCT, Lumedica, launches OQ LabScope 3.0, equipped with 3D Rendering, at BiOS and PWEST 2023

,

Lumedica Inc., known for manufacturing complete OCT systems at an affordable price, will launch the OQ LabScope 3.0 at BIOS 2023 on January 28-29, 2023. The system retains the same hallmarks of Lumedica design, a complete OCT system at an affordable price, while adding a faster A-scan rate and capability for 3D rendering to standard systems. This improved speed makes 3D rendering within the software more practical as a full volume scan of a 5 x 5 x 7 mm3 area only takes a few seconds. Visit Booth #8259 for a complete demonstration of the OQ LabScope 3.0. Bring your own samples to see how volume scans are transformed into a 3D image. Speak with experts on low-cost OCT and determine a solution that will be your need and budget. Lumedica’s OQ LabScope launched in 2017 as the first complete OCT system commercially available under $10,000. This innovation broke the barrier of entry to OCT for many scientists. At this price point even educators could use limited funds to integra...

Demo Thorlabs’ OCT Technologies at BiOS and PWEST 2023

You are invited to visit Thorlabs’ OCT team at SPIE BiOS (Booth #8331) January 28 – 29 and Photonics West (Booth #627) January 31 – February 2 in San Francisco at the Moscone Center. We will have three live OCT systems on site and would like to invite you to bring your samples for a live demo, speak with our experts, and collect the newest Thorlabs T-shirt. For those building their own OCT setups, we can walk you through a variety of integral components, such as SLDs, MEMS-VCSEL benchtop lasers, specialized fibers, and bulk optics, as well as our brand-new OCT spectrometer. Alternatively, if you have an application need but no system, come in and check out our turn-key OCT solutions based on either swept-source or spectral-domain technology. Our systems are ideal for applications in biomedicine, industrial quality control, and more. Learn more at https://youtu.be/erDiuKNoHFI. We look forward to seeing you soon!

Post-Doctoral Fellow (Translational Biomedical Optics) at Massachusetts General Hospital / Harvard Medical School

,

Division of Pulmonary and Critical Care Medicine / Department of Pathology Employer: Massachusetts General Hospital / Harvard Medical School The Hariri Optical Imaging Laboratory is a multidisciplinary research group at Massachusetts General Hospital and Harvard Medical School. The focus of the laboratory is on the design, development and clinical translation of endoscopic optical coherence tomography (OCT)-based imaging devices for microscopic detection, diagnosis and monitoring of pulmonary diseases, including lung fibrosis, smoking and vaping-related lung diseases, post-COVID lung disease and interstitial lung abnormalities. A highly motivated, independent, innovative, and organized individual with an interest in translational optical/diagnostic imaging and biomedicine is sought for a Post-Doctoral Research Fellow position. The appropriate candidate will work in a highly collaborative multidisciplinary research environment consisting of engineers, physicians and technici...

World’s First Intracranial Use of a New High-Frequency Imaging System to Directly Visualize Neurovascular Pathologies

First human procedures performed by Prof Vitor Mendes Pereira at St. Michael’s Hospital, a site of Unity Health Toronto Gentuity, LLC, an advanced imaging technology firm, today announced the first human use of the Vis-MTM High-Frequency Optical Coherence Tomography (HF-OCT) imaging system and probe. This represents a significant technological advance for the field of neurointervention, making high resolution intravascular imaging in the brain possible. “This is an incredibly exciting milestone. The direct visualization technology we evaluated here offers unprecedented potential in the diagnosis and treatment of aneurysms, stroke, intra-cranial atherosclerotic disease (ICAD) and other neurological pathologies,” said Vitor Mendes Pereira, MD. “I am proud and honored to have the opportunity to perform the first cases. The system and imaging probes performed very well, integrating with our workflow seamlessly, and provided us with important information that we cannot obtain with any ...

Senior Research Fellow in Optical Coherence Tomography – Institute of Ophthalmology University College London

Full Job Description Ref Number: B02-04320 Professional Expertise: Research and Research Support Department: School of Life & Medical Sciences (B02) Location: London Working Pattern: Full time Salary: See advert text Contract Type: Fixed-term Working Type: On site (> 80% of working time) Available For Secondment: No Closing Date: 22-Jan-2023 About us The post of Senior Research Fellow is for biophotonics research with a focus on optical coherence tomography (OCT). The research fellow will join Prof. Sarunic’s group, which is primarily based at UCL Institute of Ophthalmology and cross-appointed with the UCL Department of Medical Physics and Biomedical Engineering, for the development of novel ocular imaging technologies. The post of Senior Research Fellow offers an exciting opportunity for someone to play a key role in developing new OCT-based diagnostics in a highly successful and dynamic research Institute, as well as benefiting from the clinical collabora...

Research Scientist Opening at Topcon Healthcare

Based in Oakland, NJ, Topcon is a comprehensive diagnostic device manufacturer within the worldwide eye care community. It introduced the world’s first commercial back-of-the-eye Spectral Domain (SD) and Swept Source (SS) optical coherence tomography (OCT) systems, which have driven innovation in eye care. More recently, to develop the most efficient, pragmatic and state-of-the-art solutions, Topcon formed a new strategic division, Topcon Healthcare Solutions, whose primary objective is to create world-class software solutions for the eye care industry and beyond. The company's products enable the collection and visualization of a wide range of imaging and clinical data while providing quantitative and clinical analysis capabilities. Topcon’s software gives clinicians access to patient exam data captured from OCTs, Visual Fields, Fundus Cameras, and other Topcon and third-party devices. Topcon leverages its new data management system called Topcon Harmony, where practition...

Research Assistant / Research Associate in Biomedical Optics at University of Kent

Location:  Canterbury Salary:  £28,762 to £40,931 per annum Research Assistant (Grade 6): £28,762 - £32,348 per annum / Research Associate (Grade 7): £36,386 – 40,931 per annum Grade:  Grade 6 Research Assistant to Grade 7 Post Type:  Full Time Contract Type: Fixed Term - 36 Months Release Date:  Wednesday 04 January 2023 Closing Date:  23.59 hours GMT on Thursday 02 February 2023  (unless otherwise stated) Interview Date:  To be confirmed Reference:  NATS-159-22-R2 We are looking for an enthusiastic and ambitious researcher to join the Applied Optics Group (AOG) in the School of Physics and Astronomy at the University of Kent.  You will work in the field of miniaturised endoscopic optical coherence tomography (OCT) on a project supported by the EPSRC grant, “FoVEnOCT: Compact Forward-Viewing Endoscopic Optical Coherence Tomography”.    The research will focus on exciting new technical solutions for forward-view...

Avinger Announces 510(k) Filing of Pantheris LV

Pantheris LV Represents the Next-Generation of Onboard Image-Guided Technology for the Treatment of Peripheral Artery Disease Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today announced the Company submitted a new 510(k) application to the U.S. Food & Drug Administration (FDA) for Pantheris LV, its next-generation image-guided atherectomy system for the treatment of larger vessels, such as the SFA and popliteal arteries, where the majority of PAD procedures are performed today. Pantheris LV offers multiple benefits to physician users, including higher speed plaque excision for efficient removal of challenging occlusive tissue and multiple features to streamline and simplify user-operation, including enhanced tissue packing and removal, a radiopaque gauge to measure volume of plaque removal during the procedu...

University of Alabama at Birmingham Receives NIH Grant for Functional Categorization of Ciliary Motion in PCDt

University of Alabama at Birmingham Receives a 2023 NIH Grant for $159,882 for Functional Categorization of Ciliary Motion in PCDt.  The principal investigator is George Solomon.  Below is a summary of the proposed study. Primary Ciliary Dyskinesia (PCD) is a genetically heterogeneous disorder of motile cilia that results in progressive lung disease due to abrogated mucociliary clearance. While new understandings of the genetics have been helpful for clinical diagnostics, functional testing of cilia are needed to understand and predict phenotypic variation and response to therapy. Recent work in our laboratory has identified a link between ciliary genetics and novel ciliary phenotypes using one-micron optical coherence tomography (µOCT). We have phenotyped the ciliary beating pattern of known and novel murine PCD models. We have extended this work to humans through the use of human nasal epithelial cells. Using these technologies, we will characterize and quantify functional cili...

University of Southern California Receives NIH Grant for Mechanisms of cochlear synaptopathy after noise or blast trauma

University of Southern California Receives a 2023 NIH Grant for $516,926 for Mechanisms of cochlear synaptopathy after noise or blast trauma.  The principal investigator is John S. Oghalai.  Below is a summary of the proposed study. About 15% of Americans have hearing loss due to noise exposure. The classical explanation is trauma to the cochlear hair cells. An additional mechanism of noise-induced hearing loss is cochlear synaptopathy. There are no effective treatments used clinically to prevent hearing loss via either mechanism after traumatic noise exposure. Recently, we identified that endolymphatic hydrops occurs after blast or noise trauma, and that endolymphatic hydrops correlated with cochlear synaptopathy. Our central hypothesis is that endolymphatic hydrops is a surrogate marker for swelling of auditory nerve dendrites that occurs in response to glutamate excitotoxicity. We will test this hypothesis with three aims. First, we will determine whether swelling of auditory ...

University of Oklahoma Receives NIH Grant for Use of 3D Quantitative Optical Methods to Optimize Mebendazole Treatment of Ovarian Cancer

University of Oklahoma received a 2023 NIH Grant for $162,748 for Use of 3D Quantitative Optical Methods to Optimize Mebendazole Treatment of Ovarian Cancer.  The principal investigator is Lauren Elizabeth Dockery.  Below is a summary of the proposed study. Effective treatment for recurrent epithelial ovarian cancer is a major, unmet public health need as the response rates of the patients are often low with the traditional chemotherapy. Repurposing drugs is an increasingly popular strategy in oncology due to the financial and logistical constraints of new drug development. Recently, anti-parasitic drugs such as mebendazole have surfaced as repurposed oncology drugs and showed promise in treating multiple types of tumors. The anti-parasitic drugs, fenbendazole and mebendazole, are in the benzimidazole class and have been FDA-approved to treat pinworm and other helminthic infections in humans and animals for decades. The selectivity of these drugs for the parasite rather than the ...

Washington University Receives NIH Grant for High-throughput integrated live imaging and optogenetic pacing platform to assess hypoxia responsiveness in the fly heart

Washington University received a 2023 NIH Grant for $432,968 for High-throughput integrated live imaging and optogenetic pacing platform to assess hypoxia responsiveness in the fly heart.  The principal investigator is Chao Zhou.  Below is a summary of the proposed study. Ischemic preconditioning is a well-established phenomenon, in which a brief episode(s) of controlled ischemia and reperfusion renders cardioprotection from a subsequent sustained episode of ischemia. An emerging body of evidence demonstrated that neural regulated heart rate modulation confers cardiac preconditioning responses. Understanding the mechanism through model systems of preconditioning would help us identify the genes and proteins when designing future drug targets for the prevention of ischemic cardiac injury. As a promising alternative to electrical pacing to modulate heart rate, optogenetic pacing does not require physical contact, has high spatial and temporal precision, offers more specific excitat...

Medical College of Wisconsin Receives NIH Grant for Otitis Media Diagnosis and Treatment

Medical College of Wisconsin Receives a 2023 NIH Grant for $497,472 for Otitis Media Diagnosis and Treatment.  The principal investigator is Joseph Kerchner.  Below is a summary of the proposed study Otitis media (OM) is the most common diagnosis in pediatric patients seen for illness in the United States (1,2), affects 90% of all children (3,4) and is the most common indication for antimicrobial therapy and surgery (5) in young children. Despite many attempts to improve diagnosis, treatment, and prevention, OM continues its highly prevalent impact on children and substantial ongoing morbidity (1,3,6-30). OM continues as the most common cause of hearing loss (HL) in children and leads to speech, educational and other developmental delays (31-37). OM causes life-threatening complications (22,27) and is expensive, resulting in over $5 billion annually in U.S. health care expenditures (3,38). Despite the prevalence and difficulties with OM, diagnostic accuracy to allow appropriate t...

PhD Studentships at the BC Cancer Research Institute — In Vivo Microscopy

Would you like to work at the interface of engineering and medicine? Do you have a background in engineering or physical science and the desire to apply it to the early detection of cancer? We are accepting applications for MASc/PhD Studentships in the Optical Cancer Imagine Lab (OCIL) at the BC Cancer Research Institute. Expected start date is September 2023. See the OCIL Recruitment Page (https://biophotonics.bccrc.ca/index.php/join/) for details. Interested candidates should forward a brief cover letter that expresses their research interests, curriculum vitae, and references to Rebecca White (rebecca.white@bccrc.ca) with “PHD STUDENTSHIP 2023” in the subject line

Post Doctoral Fellowship at the BC Cancer Research Institute — In Vivo Microscopy

We are seeking a qualified individual to pursue mutually beneficial projects related to the current research program in the OCIL at the BC Cancer Research Institute. Fellowships can start early 2023. There are several research projects of interest, including but not limited to, development of OCT systems for endoscopic imaging in the 800nm band, time-resolved fluorescence imaging, and multimodal endoscopic imaging. The successful candidate will join an interdisciplinary research group including engineers, imaging scientists, and clinicians. See the OCIL Recruitment Page (https://biophotonics.bccrc.ca/index.php/join/) for details. Interested candidates should forward a cover letter that expresses their research interests, curriculum vitae, and two references to Rebecca White (rebecca.white@bccrc.ca) with “OCT PDF 2023” in the subject line.  

Categories

Organizations in the News

OCT Companies in the News

Picture Gallery